The expectation is that a structured medication review in primary care improves medication adherence and leads to positive patient outcomes in patients with Parkinson's Disease
ID
Bron
Verkorte titel
Aandoening
Parkinson's Disease
Therapy adherence
Medication
Polypharmacy
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary objective of the study is to assess whether a structured medication review improves medication adherence and leads to better quality of life in patients with PD after a follow-up of three months and six months, compared to patients with PD who will not receive a structured medication review during follow-up. Disease-specific quality of life will be measured, using the Parkinson’s Disease Questionnaire-39 (PDQ-39).
Achtergrond van het onderzoek
The aim of this study is to assess whether a structured medication review in primary care improves medication adherence and leads to positive patient outcomes in patients with PD. The expectation is that the results of this study might be used to improve daily treatment of patients with PD.
Doel van het onderzoek
The expectation is that a structured medication review in primary care improves medication adherence and leads to positive patient outcomes in patients with Parkinson's Disease
Onderzoeksopzet
- Baseline
- Three months
- Six months
Onderzoeksproduct en/of interventie
The study is a prospective randomized, controlled trial (RCT).
As intervention, community pharmacists perform a structured medication review as one-time assessment at the start of the study within the intervention group. Measurements at baseline will be done before the intervention. The follow-up measurements will take place after three months and six months.
A structured medication review can be defined as ‘a structured, critical examination of a patient’s medicines with the objective of reaching an agreement with the patient about treatment, optimizing the impact of medicines, minimizing the number of medication-related problems and reducing waste’
Publiek
P.O. Box 50000
J. Palen, van der
Enschede 7500 KA
The Netherlands
+31 (0)53 4872023
Wetenschappelijk
P.O. Box 50000
J. Palen, van der
Enschede 7500 KA
The Netherlands
+31 (0)53 4872023
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
The patient has/is:
• Diagnosed with PD according to the UK-brain banking criteria
• ≥ Eighteen years of age
• ≥ Four different medications daily
• ≥ Four medication intake moments daily
• Expressing motor symptoms or non-motor symptoms
• Living (semi)-independent in the region of Enschede
• Able to read and write the Dutch language
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
The patient has/is:
• Unable to administrate own medications, excluding PD patients with personal or family home caregivers
• Received a medication review within a year before the study
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL4360 |
| NTR-old | NTR4500 |
| CCMO | NL48661.044.14 |
| OMON | NL-OMON44681 |